Studie
Fragestellung
Quelle
A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.
Br J Cancer 6 (2009) 908-915
| zurück | JSG - Trial | |||
Studie |
Japanese Study Group | |||
Fragestellung |
Verbessert eine postoperative Chemotherapie der Ergebniss der radikalen Operation? | |||
| Ergebnis | Das Ergebnis war mit Chemotherapie besser. | |||
| - | A | B | ||
| DFS | 11,4 M | 5 M | ||
| OS | 22,3 M | 11,4 M | ||
| Behandlungs-Arm A | nach OP Gemzitabin 1000mg/q, Tag 1,8,16 q29 3x (58 Patienten) | |||
| Behandlungs-Arm B | nur OP (60 Patienten) | |||
Quelle |
Ueno H et al.: A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 6 (2009) 908-915 |
|||
| ||||
Impressum .....................................................................................Zuletzt geändert am 16.09.2012 21:13